跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
anticancer therapeutic
首页
药物
anticancer therapeutic
anticancer therapeutic
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Methods, compositions, and kits for organ protection during systemic anticancer therapy
US 6995165 B2
申请人: FORD JOHN P
优先权: 2004
US
10 件公开
THERAPEUTIC ANTICANCER NEOEPITOPE VACCINE
EP 3400004 A1
申请人: VACCIBODY AS
优先权: 2016
CN
EP
US
WO
8 件公开
Nrf-2 deficient cells and uses thereof
US 12655425 B2
申请人: NAT UNIV PUSAN IND UNIV COOP FOUND
优先权: 2018
CN
EP
US
WO
5 件公开
Individualized therapeutic anticancer vaccine
US 12691165 B2
申请人: NYKODE THERAPEUTICS ASA
优先权: 2020
CN
EP
US
WO
5 件公开
Anticancer treatment with a combination of taxanes and 13-deoxyanthracyclines
US 7776832 B2
申请人: GEM PHARMACEUTICALS LLC
优先权: 2006
CN
US
5 件公开
STRUCTURE OF ONCOLYTIC VIRUS COMPRISING BISPECIFIC NUCLEIC ACID MOLECULE
US 2023127169 A1
申请人: CURIGIN CO LTD
优先权: 2020
CN
EP
US
WO
4 件公开
BIOMARKER FOR PREDICTING THERAPEUTIC RESPONSIVENESS TO CANCER IMMUNOTHERAPEUTIC AGENT AND USE THEREOF
EP 4245865 A4
申请人: IMMUNEONCIA THERAPEUTICS INC
优先权: 2020
CN
EP
US
WO
4 件公开
COMPOSITION CONTAINING ARIPIPRAZOLE AS ACTIVE INGREDIENT FOR ENHANCING ANTICANCER EFFECT OF KRAS G12C GENETIC MUTATION THERAPEUTIC AGENT
EP 4523688 A4
申请人: KOREA INST RADIOLOGICAL & MEDICAL SCIENCES
优先权: 2022
CN
EP
US
WO
4 件公开
Radioactive therapeutic liposomes
US 6592843 B2
申请人: ANTICANCER THERAPEUTIC INV SA
优先权: 2000
CN
US
WO
4 件公开
Anticancer Effect Enhancer
US 2008039521 A1
申请人: YASUDA HIROYASU
优先权: 2004
CN
US
4 件公开
第 1 / 10 页
上一页
下一页
药物
反馈